{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:16:13Z","timestamp":1779909373477,"version":"3.53.1"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Variation in clinical practice affects veno-occlusive disease management, mainly in patients who undergo allogeneic hematopoietic stem cell transplantation. Disputes about diagnostic criteria, treatment, and prophylaxis, due to the lack of high-quality data, are at the base of this variability. With the aim of limiting inconsistency in clinical care, thus improving both patient outcomes and data collection reliability, the Italian Society of Stem cell transplant (Gruppo Italiano Trapianto Midollo Osseo e Terapia Cellulare) launched a collaborative effort to formulate recommendations based on integration of available evidence and expert\u2019s consensus. A systematic method, according to US National Institute of Health guidelines and Italian National System for Guidelines, was used. Twenty-nine recommendations were approved with a strong (20) or weak (9) level of agreement, while 26 were rejected. In particular, the panel pointed out the need to achieve an early diagnosis, encouraging the adoption of European Society for Blood and Marrow Transplantation criteria and the prompt use of ultrasonography. Moreover, our experts strongly recommended in favor of prophylactic use of ursodeoxycholic acid. As soon as a veno-occlusive disease diagnosis is established, treatment with defibrotide should be started for at least 21 days. A number of areas of uncertainty, particularly concerning risk stratification and use of diagnostic tools such as elastography has been identified and discussed.<\/jats:p>","DOI":"10.1097\/tp.0000000000003569","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T20:04:53Z","timestamp":1607025893000},"page":"686-694","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Veno-occlusive Disease in HSCT Patients: Consensus-based Recommendations for Risk Assessment, Diagnosis, and Management by the GITMO Group"],"prefix":"10.1097","volume":"105","author":[{"given":"Francesca","family":"Bonifazi","sequence":"first","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria, Istituto di Ematologia \u201cL. e A. Ser\u00e0gnoli\u201d, Bologna, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sica","sequence":"additional","affiliation":[{"name":"Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico A. Gemelli IRCCS, Roma, Italia."},{"name":"Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Universit\u00e0 Cattolica del Sacro Cuore, Roma, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Angeletti","sequence":"additional","affiliation":[{"name":"Clinica Medica, Universit\u00e0 Politecnica delle Marche, Ancona, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Marktel","sequence":"additional","affiliation":[{"name":"Unit\u00e0 di Ematologia e Trapianto di Midollo Osseo IRCCS, Istituto Scientifico Ospedale San Raffaele, Milano, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arcangelo","family":"Prete","sequence":"additional","affiliation":[{"name":"Dipartimento di Oncologia ed Ematologia Pediatrica, Universit\u00e0 di Bologna, Ospedale S. Orsola-Malpighi, Bologna, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Paola","family":"Iori","sequence":"additional","affiliation":[{"name":"Dipartimento di Oncologia ed Ematologia Pediatrica IRCCS, Ospedale Bambino Gesu\u2019, Roma, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diletta","family":"Olivari","sequence":"additional","affiliation":[{"name":"Clinica Medica, Universit\u00e0 Politecnica delle Marche, Ancona, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rossetti","sequence":"additional","affiliation":[{"name":"Clinica Medica, Universit\u00e0 Politecnica delle Marche, Ancona, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Bertaina","sequence":"additional","affiliation":[{"name":"Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Botti","sequence":"additional","affiliation":[{"name":"Unit\u00e0 di Ematologia, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Busca","sequence":"additional","affiliation":[{"name":"Dipartimento di Oncologia ed Ematologia, AOU Citta\u2019 della Salute e della Scienza, Torino, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Michele","family":"Carella","sequence":"additional","affiliation":[{"name":"Unit\u00e0 di Trapianto di Midollo Osseo, Dipartimento di Oncoematologia, Fondazione IRCCS \u201cCasa Sollievo della Sofferenza\u201d San Giovanni Rotondo, Foggia, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Cerretti","sequence":"additional","affiliation":[{"name":"UOC Ematologia, Unit\u00e0 di Trapianto di Cellule Staminali, Ospedale Tor Vergata, Roma, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"Gargiulo","sequence":"additional","affiliation":[{"name":"Dipartimento di Oncologia ed Ematologia, Azienda Ospedaliero Universitaria Federico II, Napoli, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Grassi","sequence":"additional","affiliation":[{"name":"UOS Trapianto di Midollo USC Ematologia, ASST PG23 Bergamo, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gualandi","sequence":"additional","affiliation":[{"name":"Divisione di Ematologia e Unit\u00e0 di Trapianto di Cellule Staminali, Policlinico San Martino IRCCS, Genova, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Irrera","sequence":"additional","affiliation":[{"name":"Centro Trapianti Cellule Staminali e Terapie Cellulari \u201cA.Neri,\u201d Grande Ospedale Metropolitano, Reggio Calabria, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Milone","sequence":"additional","affiliation":[{"name":"Unit\u00e0 di Trapianto Emopoietico, Azienda Ospedaliero Universitaria \u201cPoliclinico-Vittorio Emanuele,\u201d San Marco, Catania, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Maria","family":"Risitano","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Universit\u00e0 Federico II Napoli, Napoli, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Santarone","sequence":"additional","affiliation":[{"name":"Terapia Intensiva Ematologica, Dipartimento Oncologico Ematologico Ospedale Civile, Pescara, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Vassallo","sequence":"additional","affiliation":[{"name":"Dipartimento di Oncoematologia, Centro Trapianti Cellule Staminali e Terapia Cellulare, Ospedale Infantile Regina Margherita, Torino, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zecca","sequence":"additional","affiliation":[{"name":"Oncoematologia Pediatrica, Fondazione IRCCS Policlinico San Matteo, Pavia, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[{"name":"Unit\u00e0 di Ematologia e Trapianto di Midollo Osseo IRCCS, Istituto Scientifico Ospedale San Raffaele, Milano, Italia."},{"name":"Universit\u00e0 Vita-Salute San Raffaele, Milano, Italia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pomponio","sequence":"additional","affiliation":[{"name":"Clinica Medica, Ospedali Riuniti di Ancona, Ancona, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation.","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4065\/78.5.589","article-title":"Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.","volume":"78","author":"Kumar","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clinre.2016.01.006","article-title":"Sinusoidal obstruction syndrome.","volume":"40","author":"Valla","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R4-20250604","first-page":"584","article-title":"Pathogenesis of veno-occlusive liver disease after radiation.","volume":"104","author":"Fajardo","year":"1980","journal-title":"Arch Pathol Lab Med"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1016\/j.transproceed.2014.09.110","article-title":"Severe veno-occlusive disease\/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation.","volume":"46","author":"Takamura","year":"2014","journal-title":"Transplant Proc"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT.","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbmt.2018.09.027","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease after autologous or allogeneic hematopoietic stem cell transplantation in children: a retrospective study of the Italian Hematology-Oncology Association-Hematopoietic Stem Cell Transplantation Group.","volume":"25","author":"Faraci","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R10-20250604","first-page":"3599","article-title":"Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.","volume":"92","author":"Carreras","year":"1998","journal-title":"Blood"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation.","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"R12-20250604","first-page":"1396","article-title":"A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.","volume":"90","author":"Cesaro","year":"2005","journal-title":"Haematologica"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.bbmt.2011.06.006","article-title":"The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade.","volume":"17","author":"Carreras","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/bmt.2009.56","article-title":"Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome.","volume":"44","author":"Sakai","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/bjh.13215","article-title":"How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation.","volume":"168","author":"Carreras","year":"2015","journal-title":"Br J Haematol"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/bjh.15267","article-title":"Final results from a defibrotide treatment-IND study for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome.","volume":"181","author":"Kernan","year":"2018","journal-title":"Br J Haematol"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.bbmt.2016.07.001","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease: final results from the international compassionate-use program.","volume":"22","author":"Corbacioglu","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.","volume":"163","author":"Dignan","year":"2013","journal-title":"Br J Haematol"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/bmt.2015.52","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT).","volume":"50","author":"Mohty","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/bmt.2016.300","article-title":"Veno-occlusive disease\/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East\/North Africa regional consensus on prevention, diagnosis and management.","volume":"52","author":"Al Jefri","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/bmt.2016.130","article-title":"Revised diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.","volume":"51","author":"Mohty","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","article-title":"Venoocclusive disease of the liver following bone marrow transplantation.","volume":"44","author":"Jones","year":"1987","journal-title":"Transplantation"},{"key":"R23-20250604","first-page":"197","article-title":"Hepatic veno-occlusive disease\u2013liver toxicity syndrome after bone marrow transplantation.","volume":"10","author":"Shulman","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/135581969900400410","article-title":"Consensus development methods: a review of best practice in creating clinical guidelines.","volume":"4","author":"Black","year":"1999","journal-title":"J Health Serv Res Policy"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bmj.38987.492014.94","article-title":"How to formulate research recommendations.","volume":"333","author":"Brown","year":"2006","journal-title":"BMJ"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"a744","DOI":"10.1136\/bmj.a744","article-title":"Use of GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive.","volume":"337","author":"Jaeschke","year":"2008","journal-title":"BMJ"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbmt.2015.09.024","article-title":"Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: risk factors and stratification, prophylaxis, and treatment.","volume":"22","author":"Dalle","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.bbmt.2019.02.018","article-title":"Risk factors for development of and progression of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome.","volume":"25","author":"Corbacioglu","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1016\/S2352-3026(17)30103-5","article-title":"Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study.","volume":"4","author":"Kantarjian","year":"2017","journal-title":"Lancet Haematol"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1509277","article-title":"Inotuzumab ozogamicin for acute lymphoblastic leukemia.","volume":"375","author":"Kantarjian","year":"2016","journal-title":"N Engl J Med"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41409-017-0019-y","article-title":"Management of important adverse events associated with inotuzumab ozogamicin: expert panel review.","volume":"53","author":"Kebriaei","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/pbc.23198","article-title":"Iron chelation with Deferasirox prior to high-dose chemotherapy and autologous stem cell transplantation may reduce the risk of hepatic veno-occlusive disease in children with high-risk solid tumor.","volume":"58","author":"Chueh","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/j.1875-9114.2012.01034.x","article-title":"Possible correlation of sirolimus plasma concentration with sinusoidal obstructive syndrome of the liver in patients undergoing myeloablative allogeneic hematopoietic cell transplantation.","volume":"32","author":"Kiel","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"12 Pt 1","key":"R38-20250604","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00002","article-title":"Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.","volume":"128","author":"Essell","year":"1998","journal-title":"Ann Intern Med"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","article-title":"The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation.","volume":"64","author":"Ohashi","year":"2000","journal-title":"Am J Hematol"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R42-20250604","first-page":"CD009311","article-title":"Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.","volume":"27","author":"Cheuk","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbmt.2008.12.489","article-title":"Busulfan in hematopoietic stem cell transplantation.","volume":"15","author":"Ciurea","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/bmt.2008.404","article-title":"The effect of administration order of BU and CY on toxicity in hematopoietic SCT in humans.","volume":"43","author":"Kerbauy","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/bmt.2010.137","article-title":"Order of application and liver toxicity in patients given BU and CY containing conditioning regimens for allogeneic hematopoietic SCT.","volume":"46","author":"Cantoni","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.bmt.1702377","article-title":"The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity.","volume":"25","author":"Hassan","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl","key":"R48-20250604","first-page":"231","article-title":"Efficacy and safety of defibrotide in the treatment of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome following hematopoietic stem cell transplantation: interim results from the defifrance study.","volume":"54","author":"Mohty","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.bbmt.2018.05.025","article-title":"Novel ultrasonographic scoring system of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation.","volume":"24","author":"Nishida","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/17474124.2019.1588111","article-title":"Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review.","volume":"13","author":"Ravaioli","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jvir.2012.09.011","article-title":"Safety and utility of transjugular liver biopsy in hematopoietic stem cell transplant recipients.","volume":"24","author":"Kis","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"R52-20250604","first-page":"21","article-title":"Transjugular liver biopsy in BMT.","volume":"11","author":"Carreras","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/00007890-199504150-00017","article-title":"Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients.","volume":"59","author":"Shulman","year":"1995","journal-title":"Transplantation"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1097\/MPH.0b013e3182025236","article-title":"Safety and utility of liver biopsy after pediatric hematopoietic stem cell transplantation.","volume":"33","author":"Oshrine","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/MPG.0000000000002587","article-title":"Transjugular versus percutaneous liver biopsy in children: indication, success, yield, and complications.","volume":"70","author":"Srivastava","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","article-title":"The clinical use of HVPG measurements in chronic liver disease.","volume":"6","author":"Bosch","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1053\/j.gastro.2012.02.017","article-title":"Noninvasive methods to assess liver disease in patients with hepatitis B or C.","volume":"142","author":"Castera","year":"2012","journal-title":"Gastroenterology"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/j.gastro.2012.05.035","article-title":"Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis.","volume":"143","author":"Colecchia","year":"2012","journal-title":"Gastroenterology"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/bmt.2016.320","article-title":"Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT.","volume":"52","author":"Colecchia","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.bbmt.2019.01.019","article-title":"Liver stiffness measurement allows early diagnosis of veno-occlusive disease\/sinusoidal obstruction syndrome in adult patients who undergo hematopoietic stem cell transplantation: results from a monocentric prospective study.","volume":"25","author":"Colecchia","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41409-017-0064-6","article-title":"Using liver elastography to diagnose sinusoidal obstruction syndrome in pediatric patients undergoing hematopoetic stem cell transplant.","volume":"55","author":"Reddivalla","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41409-019-0464-x","article-title":"Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurement.","volume":"54","author":"Karlas","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3332\/ecancer.2016.661","article-title":"Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group.","volume":"10","author":"Botti","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"P514","DOI":"10.1186\/cc8746","article-title":"Use of CRRT-CVVH in a hemato-oncological ICU in patients treated with defibrotide for veno-occlusive disease in patients after allogeneic hematopoetic stem cell transplantation: single-center experience.","volume":"14","author":"Navratil","year":"2010","journal-title":"Crit Care"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"e395","DOI":"10.1097\/MPH.0000000000001455","article-title":"Role of initiating supportive care preceding veno-occlusive disease diagnosis following allogeneic hematopoietic stem cell transplantation in children.","volume":"41","author":"Rayner","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/bmt.2013.101","article-title":"Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA.","volume":"48","author":"Yoon","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2352-3026(19)30201-7","article-title":"Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement.","volume":"7","author":"Mahadeo","year":"2020","journal-title":"Lancet Haematol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:14:51Z","timestamp":1749064491000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003569","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}